175 related articles for article (PubMed ID: 9464545)
41. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
Chatterjee SJ; George B; Goebell PJ; Alavi-Tafreshi M; Shi SR; Fung YK; Jones PA; Cordon-Cardo C; Datar RH; Cote RJ
J Pathol; 2004 Jul; 203(3):762-70. PubMed ID: 15221935
[TBL] [Abstract][Full Text] [Related]
42. Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.
Kitahara K; Yasui W; Yokozaki H; Semba S; Hamamoto T; Hisatsugu T; Tahara E
J Exp Ther Oncol; 1996 Jan; 1(1):7-12. PubMed ID: 9414383
[TBL] [Abstract][Full Text] [Related]
43. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
44. Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells.
Duan J; Chen Z; Liu P; Zhang Z; Tong T
Int J Oncol; 2004 Jun; 24(6):1597-605. PubMed ID: 15138605
[TBL] [Abstract][Full Text] [Related]
45. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
Jarrard DF; Sarkar S; Shi Y; Yeager TR; Magrane G; Kinoshita H; Nassif N; Meisner L; Newton MA; Waldman FM; Reznikoff CA
Cancer Res; 1999 Jun; 59(12):2957-64. PubMed ID: 10383161
[TBL] [Abstract][Full Text] [Related]
46. Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2'-deoxycytidine treatment induces a senescence-like state.
Timmermann S; Hinds PW; Münger K
Oncogene; 1998 Dec; 17(26):3445-53. PubMed ID: 10030668
[TBL] [Abstract][Full Text] [Related]
47. RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.
Mack PC; Gandara DR; Bowen C; Edelman MJ; Paglieroni T; Schnier JB; Gelmann EP; Gumerlock PH
Clin Cancer Res; 1999 Sep; 5(9):2596-604. PubMed ID: 10499638
[TBL] [Abstract][Full Text] [Related]
48. [Expression and regulation of p16 in osteosarcoma].
Shi X; Ma Z; Wang D; Liang Y; Li H; Wang J
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):733-6. PubMed ID: 11829939
[TBL] [Abstract][Full Text] [Related]
49. 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.
Halloran CM; Ghaneh P; Shore S; Greenhalf W; Zumstein L; Wilson D; Neoptolemos JP; Costello E
J Gene Med; 2004 May; 6(5):514-25. PubMed ID: 15133762
[TBL] [Abstract][Full Text] [Related]
50. p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways.
Steiner MS; Wang Y; Zhang Y; Zhang X; Lu Y
Oncogene; 2000 Mar; 19(10):1297-306. PubMed ID: 10713671
[TBL] [Abstract][Full Text] [Related]
51. Alteration of pRb/p16/cdk4 regulation in human osteosarcoma.
Benassi MS; Molendini L; Gamberi G; Ragazzini P; Sollazzo MR; Merli M; Asp J; Magagnoli G; Balladelli A; Bertoni F; Picci P
Int J Cancer; 1999 Oct; 84(5):489-93. PubMed ID: 10502725
[TBL] [Abstract][Full Text] [Related]
52. Effects of adenovirus-mediated expression of p27Kip1, p21Waf1 and p16INK4A in cell lines derived from t(2;5) anaplastic large cell lymphoma and Hodgkin's disease.
Turturro F; Arnold MD; Frist AY; Seth P
Leuk Lymphoma; 2002 Jun; 43(6):1323-8. PubMed ID: 12153002
[TBL] [Abstract][Full Text] [Related]
53. Expression of p16INK4a suppresses the unbounded and anchorage-independent growth of a glioblastoma cell line that lacks p16INK4a.
Higashi H; Suzuki-Takahashi I; Yoshida E; Nishimura S; Kitagawa M
Biochem Biophys Res Commun; 1997 Feb; 231(3):743-50. PubMed ID: 9070885
[TBL] [Abstract][Full Text] [Related]
54. Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells.
Schwartz B; Avivi-Green C; Polak-Charcon S
Mol Cell Biochem; 1998 Nov; 188(1-2):21-30. PubMed ID: 9823007
[TBL] [Abstract][Full Text] [Related]
55. [Effects of adenovirus-mediated p16 and p53 genes transfer on apoptosis and cell cycle of lung carcinoma cells].
Bai X; Che F; Li J; Ma Y; Zhou Y; Zhai J; Meng L
Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):354-8. PubMed ID: 11866935
[TBL] [Abstract][Full Text] [Related]
56. Alteration of the CDKN2/p16 gene is not required for HPV-positive uterine cervical cancer cell lines.
Yoshinouchi M; Hongo A; Takamoto N; Ono Y; Nagao S; Miyagi Y; Kudo T; Kodama J
Int J Oncol; 2000 Mar; 16(3):537-41. PubMed ID: 10675486
[TBL] [Abstract][Full Text] [Related]
57. Induction of beta-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1.
Cozar-Castellano I; Takane KK; Bottino R; Balamurugan AN; Stewart AF
Diabetes; 2004 Jan; 53(1):149-59. PubMed ID: 14693709
[TBL] [Abstract][Full Text] [Related]
58. Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells.
Katsuda K; Kataoka M; Uno F; Murakami T; Kondo T; Roth JA; Tanaka N; Fujiwara T
Oncogene; 2002 Mar; 21(13):2108-13. PubMed ID: 11960384
[TBL] [Abstract][Full Text] [Related]
59. Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest.
Sheahan S; Bellamy CO; Dunbar DR; Harrison DJ; Prost S
BMC Cancer; 2007 Nov; 7():215. PubMed ID: 18021445
[TBL] [Abstract][Full Text] [Related]
60. Adenovirus p16 gene therapy for prostate cancer.
Allay JA; Steiner MS; Zhang Y; Reed CP; Cockroft J; Lu Y
World J Urol; 2000 Apr; 18(2):111-20. PubMed ID: 10854145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]